ArticleHepatobiliary surgery and nutrition2026
Immune-mediated adverse events as a window into antitumor immunity in hepatocellular carcinoma: lessons and future directions from the HIMALAYA trial.
Takehiro OkabayashiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.